|
OXB
|
Oxford Biomedica Plc
|
UK
|
LSE
|
|
PAB
|
Patrys Limited
|
AU
|
ASX
|
|
PANC
|
Panacos Pharmaceuticals Inc
|
US
|
US
|
|
PANG
|
Pangaea Oncology S.A.
|
ES
|
MC
|
|
PAR
|
Paradigm Biopharmaceuticals Ltd
|
AU
|
ASX
|
|
PARD
|
Poniard Pharmaceuticals Inc
|
US
|
US
|
|
PBLA
|
Panbela Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PBM
|
Psyence Biomedical Ltd. Common Shares
|
US
|
US
|
|
PBN0
|
ALTERITY THERAP.ADR/600
|
DE
|
F
|
|
PBT
|
Prana Biotechnology Ltd
|
AU
|
ASX
|
|
PBYI
|
Puma Biotechnology Inc
|
US
|
NASDAQ
|
|
PCIB
|
PCI Biotech Holding ASA
|
NO
|
OL
|
|
PCJ
|
ABEONA THERAPEUT. DL-01
|
DE
|
F
|
|
PCNEF
|
Precision System Science Co. Ltd.
|
US
|
US
|
|
PFND
|
Pathfinder Cell Therapy Inc
|
US
|
US
|
|
PH7
|
Phylogica Limited
|
DE
|
MU
|
|
PHAS
|
PhaseBio Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PHIO
|
Phio Pharmaceuticals Corp.
|
US
|
NASDAQ
|
|
PHXM
|
PHAXIAM Therapeutics S.A.
|
FR
|
PA
|
|
PIRS
|
Pieris Pharmaceuticals, Inc.
|
US
|
NASDAQ
|